Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Market Access & Health Policy
Journal of Market Access & Health Policy Journal Specifications
Indexed in the following public directories
Scopus
DOAJ
SJR
| Overview | |
| Publisher | Taylor & Francis Group |
| Language | English |
| Article Processing Charges | GBP 1190 |
| Publication Time | 14 |
| Editorial Review Process | Double blind peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Journal of Market Access & Health Policy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Market Access & Health Policy
Economic evaluations of hypertension interventions in pregnancy lack standardisation: results of a systematic review.
- 6 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Swimming in the Sea of Real-World Evidence (RWE) Guidance: Why More Guidance Documents Are Needed to Help Researchers Swim.
- 6 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Swimming in the Sea of RWE Guidance: Why More Guidance Will Not Help Researchers Swim.
- 6 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Reasons for distributional preferences for health outcomes: A mixed method interview study.
- 6 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Reframing NICE's Cost-Effectiveness Threshold: Technical Benchmark or Policy Signal? A Documentary Content Analysis.
- 6 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Psychometric evaluation of self- and proxy-reported EQ-5D-Y-3L and EQ-5D-Y-5L in children with Attention-deficit/hyperactivity disorder.
- 5 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Economic evaluations of hypertension interventions in pregnancy lack standardisation: results of a systematic review.
- 6 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Swimming in the Sea of Real-World Evidence (RWE) Guidance: Why More Guidance Documents Are Needed to Help Researchers Swim.
- 6 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Swimming in the Sea of RWE Guidance: Why More Guidance Will Not Help Researchers Swim.
- 6 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Reasons for distributional preferences for health outcomes: A mixed method interview study.
- 6 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Reframing NICE's Cost-Effectiveness Threshold: Technical Benchmark or Policy Signal? A Documentary Content Analysis.
- 6 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Psychometric evaluation of self- and proxy-reported EQ-5D-Y-3L and EQ-5D-Y-5L in children with Attention-deficit/hyperactivity disorder.
- 5 Aug 2026
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research